trending Market Intelligence /marketintelligence/en/news-insights/trending/rmuyyq3hxcfvgxf2cchdsw2 content esgSubNav
In This List

Processa Pharmaceuticals appoints CFO

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Processa Pharmaceuticals appoints CFO

Processa Pharmaceuticals Inc. appointed James Stanker as its CFO.

The Hanover, Md.-based company said Stanker brings more than 25 years of financial and executive leadership experience to Processa in the areas of accounting principles and audit standards, regulatory reporting and fiscal management and strategy.

Processa Pharmaceuticals is developing a medicine for a skin condition known as necrobiosis lipoidica.